The answer so far

Start with the intended outcome: swallowing, applying to skin and injecting create different barriers and exposure. Evidence for one route does not automatically transfer to another.

The route—swallowing, applying to skin or injection—changes the barriers a substance meets and can change how much reaches its target, how quickly it acts and what risks matter. Products with the same ingredient name are not automatically interchangeable: formulation, intended use and route-specific evidence matter too.12

On this page
  1. By mouth: a journey through the digestive system
  2. On the skin: a protective barrier
  3. Injection: several distinct routes
  4. The same name does not mean the same product
  5. What to ask before comparing a claim
  6. Sources
Follow this question
Why does the way a medicine or supplement enters the body matter? Choose a step to explore this subject in more detail.
  1. 1By mouth: a journey through the digestive system
  2. 2On the skin: a protective barrier
  3. 3Injection: several distinct routes
  4. 4The same name does not mean the same product

By mouth: a journey through the digestive system

A swallowed tablet, capsule or liquid reaches the digestive tract. Some of its ingredient may be absorbed into the bloodstream, while some may be broken down or leave the body unabsorbed. Food, formulation and the substance itself can change absorption. For some medicines, metabolism in the gut and liver before the wider circulation—called first-pass metabolism—reduces the amount reaching it.1234

On the skin: a protective barrier

Skin helps protect the body and can restrict what passes through it. A cream may be designed to act mainly where applied; a specially formulated patch may deliver a medicine through the skin for an effect elsewhere. One cannot assume that a skin product reaches the bloodstream or target in the same way as a swallowed product.1234

Injection: several distinct routes

An injection can deliver a product into a vein, muscle or tissue beneath the skin; these routes do not all act at the same speed or in the same way. Injectable products have route-specific quality requirements, and contamination or unsafe handling can cause infection. A product sold for research, swallowing or skin application is not thereby suitable for injection.1234

The same name does not mean the same product

The amount on a label, inactive ingredients, absorption and intended effect can differ between formulations. For example, some semaglutide products are tablets and others are injections, with separate US product instructions. That does not make their amounts or handling interchangeable. See the named-product storage comparison and check the current label for your country.1234

What to ask before comparing a claim

Ask which exact formulation and route were studied, in whom, and which outcome was measured. Results from a cream or laboratory experiment do not establish the benefit or safety of an injected product. The GHK-Cu comparison and research-peptide storage guide show why. Ask a pharmacist or prescriber about your specific product rather than changing routes yourself.1234

Further reading

Trusted external resources selected to help explain this page. They open in a new tab.

Sources, kept close.

Selected supporting sources; this is not a complete literature review.

  1. Pharmacokinetics and PharmacodynamicsOpen RN / NCBI Bookshelf · Open-access pharmacology teaching textAccess checked 2026-11-04 · General teaching material on routes and absorption, not evidence of product interchangeability. Direct retrieval returned a browser-validation challenge on 4 November 2026.
  2. Preventing Unsafe Injection PracticesU.S. Centers for Disease Control and Prevention · Public-health clinical guidanceAccess checked 2026-11-04 · Source date: 2024-03-26 · Infection-prevention guidance for healthcare settings; not instructions to prepare or inject unapproved products.
  3. Ozempic injection: US prescribing information, May 2026U.S. Food and Drug Administration · FDA-approved prescribing informationAccess checked 2026-11-04 · Source date: 2026-05 · US pen and single-dose syringe label; the prescribing section is dated May 2026, and some instructions for use are dated June 2026. Check the current product and country.
  4. Rybelsus and Ozempic tablets: US prescribing information, January 2026U.S. Food and Drug Administration · FDA-approved prescribing informationAccess checked 2026-11-04 · Source date: 2026-01 · US Rybelsus and Ozempic tablets, not injectable forms.

The next useful question.